Industry Trend Report|The Future of the Biotech Industry: CDMO (Contract Development and Manufacturing Services)

A COVID-19 event has created CDMO fever in the global biotech industry. In order to seize the market opportunity which can reach US$242.64 billion by 2026, CDMO ... Read more

2023-06-06t00:09:21+08:002022/09/23|Categories: 大健康(Healthcare)|Tags: |

Industry Trend Report|Taiwan's Pigment Epithelial Derivative Factor (PEDF) New Drugs Differentiated R&D and Flexible Business Model for Global Deployment

In recent years, there have been a number of small molecule peptide research and development companies in China, ranging from upstream APIs such as ScinoPharm and Jianyi Biotech, to new drug development companies such as Quanfu and Taiwan Microsystems. ... Read more

2023-06-06t00:12:28+08:002022/09/02|Categories: 大健康(Healthcare)|Tags: , |

Industry Trend Report|New Drugs for Ophthalmology and Degenerative Arthritis Market: Recent Developments

International Ophthalmology Companies Positioned in Gene Therapy As the policies of Europe and the United States in recent years have encouraged the development of rare disease drugs, which are entitled to a tax deduction for trial expenses and an exclusivity period of 7-10 years, coupled with the fact that the rare disease drug ... Read more

2023-06-06t00:12:49+08:002022/09/02|Categories: 大健康(Healthcare)|Tags: , , |

Industry Trend Report|Stem Cell Research Advances New Drugs for Dry Eye and Degenerative Arthritis

Stem Cell Research Fuels New Drug Development Small molecule drugs are expanding in the direction of drug development thanks to advances in cell biology research on stem cells and immunomodulation. ... Read more

Go to Top